Updated on 11 August 2016
Singapore:The latest in a string of scandals related to Novartis comes from Korea. As reported by the Korean Herald, six incumbent and former executives of the South Korean unit of Swiss pharmaceutical giant Novartis have been indicted on charges of providing illegal kickbacks to doctors.
Seoul Western District Prosecutors' Office has charged the six, including the company's former CEO surnamed Mr Moon, for allegedly providing money or other rewards known in the industry as rebates to doctors in exchange for prescribing Novartis' medicines.
The sources also confirmed that nearly 23 people were involved in the scandal, including six publishers of medical publications and doctors engaging in kickback-related deals.
In response to the charges, Novartis reiterated its lack of tolerance for this type of misconduct. According to the company's website: "Our live and computer-based programs include, but are not limited to, meaningful discussion of the application and consequences of the False Claims Act, Anti-Kickback Statute, OIG Compliance Program Guidance, PhRMA Code on Interactions with Healthcare Professionals, as well as other applicable federal, state, and industry rules and guidelines."